ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125 | -18.3% | 18,684 | +2.7% | 0.00% | – |
| Q2 2023 | $153 | -84.7% | 18,200 | +4818.9% | 0.00% | – |
| Q2 2022 | $1,000 | -99.3% | 370 | -98.9% | 0.00% | – |
| Q1 2022 | $143,000 | +10.9% | 32,203 | 0.0% | 0.00% | – |
| Q4 2021 | $129,000 | -54.6% | 32,203 | -0.4% | 0.00% | – |
| Q3 2021 | $284,000 | -39.6% | 32,332 | -22.1% | 0.00% | – |
| Q2 2021 | $470,000 | +993.0% | 41,500 | +135.8% | 0.00% | – |
| Q1 2020 | $43,000 | -57.8% | 17,600 | 0.0% | 0.00% | – |
| Q4 2019 | $102,000 | +9.7% | 17,600 | 0.0% | 0.00% | – |
| Q3 2019 | $93,000 | -12.3% | 17,600 | 0.0% | 0.00% | – |
| Q2 2019 | $106,000 | -33.3% | 17,600 | 0.0% | 0.00% | – |
| Q1 2019 | $159,000 | +8.9% | 17,600 | 0.0% | 0.00% | – |
| Q4 2018 | $146,000 | -39.9% | 17,600 | 0.0% | 0.00% | – |
| Q3 2018 | $243,000 | +73.6% | 17,600 | 0.0% | 0.00% | – |
| Q2 2018 | $140,000 | – | 17,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |